Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness.

Related Articles Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness. Respir Physiol Neurobiol. 2018 Jan;247:146-155 Authors: Morélot-Panzini C, O’Donnell CR, Lansing RW, Schwartzstein RM, Banzett RB Abstract Aerosolized furosemide has been shown to relieve dyspnea; nevertheless, all published studies have shown great variability in response. This dyspnea relief is thought to result from the stimulation of slowly adapting pulmonary stretch receptors simulating larger tidal volume. We hypothesized that better control over aerosol administration would produce more consistent dyspnea relief; we used a clinical ventilator to control inspiratory flow and tidal volume. Twelve healthy volunteers inhaled furosemide (40mg) or…
Origen: Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness. – PubMed